Lovisa Afzelius
General Partner
Belmont, Massachusetts
Lovisa Afzelius, General Partner is an active investor based in Belmont, Massachusetts. This profile covers what Lovisa Afzelius backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCInvestor
- Stages
- Series A
- Invests in
- Biotech & Pharma
- Location
- Belmont, Massachusetts
- Typical check
- $1M
- Past investments
- 1
Notable investments
How to reach Lovisa Afzelius
Angels and operators like Lovisa Afzelius reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Lovisa Afzelius
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Lovisa Afzelius invest in?
Lovisa Afzelius invests in Biotech & Pharma, typically at Series A. Match your sector and stage, then reach out with a personalized pitch.
What stage does Lovisa Afzelius invest at?
Lovisa Afzelius typically invests at Series A. Lead with traction that fits the stage when you reach out.
What is Lovisa Afzelius's typical check size?
Lovisa Afzelius typically writes checks around $1M. Use it as a signal for whether your raise fits their stage.
How do I contact Lovisa Afzelius?
Unlock Lovisa Afzelius's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.